Imaging and neurochemical markers for diagnosis and disease progression in ALS
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 191 (1-2) , 35-41
- https://doi.org/10.1016/s0022-510x(01)00628-1
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Treatment of amyotrophic lateral sclerosis— What is the next step?Zeitschrift für Neurologie, 2000
- In reverse gearNature, 2000
- Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's DiseaseCell, 2000
- Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosisNature Medicine, 1999
- Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1Journal of Neuroscience, 1998
- An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With RiluzoleArchives of Neurology, 1998
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993